Assignee
TREVENA INC
US·21 granted patents·15 pending applications·53 citations·filing 2013–2023
Top patents by PatentIndex Score
36 records- 0195US9849119B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2017·Granted Dec 26, 2017·6 cites·36 claims
- 0295US9309234B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2015·Granted Apr 12, 2016·7 cites·31 claims
- 0394US9642842B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2016·Granted May 9, 2017·6 cites·33 claims
- 0489US8809260B2β-arrestin effectors and compositions and methods of use thereofTREVENA INC·Filed 2013·Granted Aug 19, 2014·7 cites·16 claims
- 0588US11077098B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2017·Granted Aug 3, 2021·2 cites·20 claims
- 0685US11225487B27-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2018·Granted Jan 18, 2022·3 cites·17 claims
- 0785US10246436B26-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2016·Granted Apr 2, 2019·5 cites·18 claims
- 0885US8796204B2β-arrestin effectors and compositions and methods of use thereofTREVENA INC·Filed 2013·Granted Aug 5, 2014·4 cites·20 claims
- 0983US11465980B26-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2019·Granted Oct 11, 2022·2 cites·16 claims
- 1083US9534017B2Beta-arrestin effectors and compositions and methods of use thereofTREVENA INC·Filed 2014·Granted Jan 3, 2017·3 cites·19 claims
- 1180US8993511B2β-arrestin effectors and compositions and methods of use thereofTREVENA INC·Filed 2014·Granted Mar 31, 2015·2 cites·25 claims
- 1280US8946142B2Beta-arrestin effectors and compositions and methods of use thereofTREVENA INC·Filed 2013·Granted Feb 3, 2015·3 cites·19 claims
- 1379US11931350B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2021·Granted Mar 19, 2024·0 cites·20 claims
- 1477US11912693B2Compounds for modulating S1P1 activity and methods of using the sameTREVENA INC·Filed 2018·Granted Feb 27, 2024·1 cites·8 claims
- 1573US11884655B2Compounds and methods of preparing compounds S1P1 modulatorsTREVENA INC·Filed 2020·Granted Jan 30, 2024·1 cites·17 claims
- 1673US11702408B25-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2018·Granted Jul 18, 2023·1 cites·14 claims
- 1773US10588898B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2019·Granted Mar 17, 2020·0 cites·17 claims
- 1873US2023203002A16-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2022·Application pending·0 cites
- 1970US2023234946A1Compounds for modulating s1p1 activity and methods of using the sameTREVENA INC·Filed 2023·Application pending·0 cites
- 2065US11912713B27-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2021·Granted Feb 27, 2024·0 cites·17 claims
- 2163US2024025949A1Beta-Arrestin Effectors and Compositions and Methods of Use ThereofTREVENA INC·Filed 2022·Application pending·0 cites
- 2262US2023303531A15-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2023·Application pending·0 cites
- 2362US2017298094A1Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofTREVENA INC·Filed 2016·Application pending·0 cites
- 2457US2015166604A1Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofTREVENA INC·Filed 2015·Application pending·0 cites
- 2556US2021324005A1Beta-Arrestin Effectors and Compositions and Methods of Use ThereofTREVENA INC·Filed 2021·Application pending·0 cites
- 2655US2015105316A1Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofTREVENA INC·Filed 2014·Application pending·0 cites
- 2754US2024317728A1Compounds and methods of preparing compounds s1p1 modulatorsTREVENA INC·Filed 2023·Application pending·0 cites
- 2853US2023114241A1Methods of treating epilepsy using the sameTREVENA INC·Filed 2020·Application pending·0 cites
- 2947US2023391749A1Crystalline and amorphous forms of a delta-opioid modulatorTREVENA INC·Filed 2021·Application pending·0 cites
- 3045US9611293B2Synthesis of beta-arrestin effectorsTREVENA INC·Filed 2015·Granted Apr 4, 2017·0 cites·12 claims
- 3144US2018016301A1Synthesis of Beta-Arrestin EffectorsTREVENA INC·Filed 2017·Application pending·0 cites
- 3242US9518086B2Crystalline and amorphous forms of a β-arrestin effectorTREVENA INC·Filed 2015·Granted Dec 13, 2016·0 cites·25 claims
- 3339US10588889B2Methods of treating hyperalgesiaTREVENA INC·Filed 2016·Granted Mar 17, 2020·0 cites·16 claims
- 3439US2021023043A1Methods of Treating HyperalgesiaTREVENA INC·Filed 2020·Application pending·0 cites
- 3538US2019008803A1Combinations of opioid receptor ligands and cytochrome p450 inhibitorsTREVENA INC·Filed 2016·Application pending·0 cites
- 3638US2017283464A1Crystalline And Amorphous Forms Of A Beta-Arrestin EffectorTREVENA INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TREVENA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →